Researchers at McMaster University have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite ...
Scientists have uncovered the precise molecular trigger behind a rare blood-clotting disorder linked to certain COVID-19 ...
For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...
Acquired Factor V inhibitors represent a rare and heterogeneous group of coagulation disorders, characterised by the sudden emergence of autoantibodies that neutralise factor V, a critical cofactor in ...
Coagulation disorders in canine medicine encompass a range of conditions in which the delicate balance between procoagulant and anticoagulant processes is disturbed. Disorders such as ...
Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...
The term “rare blood disorders” describes less common conditions that affect blood cells’ ability to function correctly. Myeloproliferative disorders and lymphoproliferative disorders are two types of ...
A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...
Researchers at McMaster University have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results